Management of the potential organ donor

Transplantation Reviews

Volumn 21, Issue 4, 2007, Pages 204-218

  Wood, Kenneth E ^a   McCartney, John ^a  

^a University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; ARGIPRESSIN; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; ESMOLOL; HYPERTENSIVE AGENT; INSULIN; LIOTHYRONINE; MANNITOL; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; NICARDIPINE; NORADRENALIN; STEROID; THYROID HORMONE; THYROXINE; URAPIDIL; VASOACTIVE AGENT; VASOPRESSIN;

ARTICLE; ARTIFICIAL VENTILATION; AUTONOMIC DYSFUNCTION; BRAIN DEATH; BRAIN HERNIA; BREATHING EXERCISE; CADAVER DONOR; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DIABETES INSIPIDUS; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FLUID RESUSCITATION; GRAFT DYSFUNCTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART DISEASE; HEART MUSCLE NECROSIS; HEART TRANSPLANTATION; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG DISEASE; LUNG TRANSPLANTATION; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; PATIENT MONITORING; POSITIVE END EXPIRATORY PRESSURE; QUALITY OF LIFE; REPEATED DRUG DOSE; SUBARACHNOID HEMORRHAGE; SURVIVAL RATE;

EID: 34848918577     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trre.2007.07.007     Document Type: Article

References (63)

1. Banki N.M., and Zaroff J.G. Neurogenic cardiac injury. Curr Treat Options Cardiovasc Med 5 (2003) 451-458
2. Banki N.M., Kopelnik A., Dae M.W., et al. Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation 112 (2005) 3314-3319
3. Tung P., Kopelnik A., Banki N., et al. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke 35 (2004) 548-551
4. Powner D.J., Boccalandro C., Alp M.S., and Vollmer D.G. Endocrine failure after traumatic brain injury in adults. Neurocrit Care 5 (2006) 61-70
5. Schneider M., Schneider H.J., and Stalla G.K. Anterior pituitary hormone abnormalities following traumatic brain injury. J Neurotrauma 22 (2005) 937-946
6. Dimopoulou I., Tsagarakis S., Theodorakopoulou M., et al. Endocrine abnormalities in critical care patients with moderate-to-severe head trauma: incidence, pattern and predisposing factors. Intensive Care Med 30 (2004) 1051-1057
7. Audibert G., Charpentier C., Seguin-Devaux C., et al. Improvement of donor myocardial function after treatment of autonomic storm during brain death. Transplantation 82 (2006) 1031-1036
8. Segel L.D., vonHaag D.W., Zhang J., and Follette D.M. Selective overexpression of inflammatory molecules in hearts from brain-dead rats. J Heart Lung Transplant 21 (2002) 804-811
9. Szabo G., Buhmann V., Bahrle S., Vahl C.F., and Hagl S. Brain death impairs coronary endothelial function. Transplantation 73 (2002) 1846-1848
10. Mehra M.R., Uber P.A., Ventura H.O., Scott R.L., and Park M.H. The impact of mode of donor brain death on cardiac allograft vasculopathy: an intravascular ultrasound study. J Am Coll Cardiol 43 (2004) 806-810
11. Anyanwu A.C., Banner N.R., Mitchell A.G., Khaghani A., and Yacoub M.H. Low incidence and severity of transplant-associated coronary artery disease in heart transplants from live donors. J Heart Lung Transplant 22 (2003) 281-286
12. Szabo G. Physiologic changes after brain death. J Heart Lung Transplant 23 (2004) S223-S226
13. Rosendale J.D., Chabalewski F.L., McBride M.A., Garrity E.R., Rosengard B.R., Delmonico F.L., and Kauffman H.M. Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant 2 (2002) 761-768
14. Salim A., Martin M., Brown C., Belzberg H., Rhee P., and Demetriades D. Complications of brain death: frequency and impact on organ retrieval. Am Surg 72 (2006) 377-381
15. Salim A., Martin M., Brown C., Rhee P., Demetriades D., and Belzberg H. The effect of a protocol of aggressive donor management: implications for the national organ donor shortage. J Trauma 61 (2006) 429-433 [discussion 433-25]
16. Hornby K., Ross H., Keshavjee S., Rao V., and Shemie S.D. Non-utilization of hearts and lungs after consent for donation: a Canadian multicentre study. Can J Anaesth 53 (2006) 831-837
17. Zaroff J.G., Babcock W.D., and Shiboski S.C. The impact of left ventricular dysfunction on cardiac donor transplant rates. J Heart Lung Transplant 22 (2003) 334-337
18. Dujardin K.S., McCully R.B., Wijdicks E.F., Tazelaar H.D., Seward J.B., McGregor C.G., and Olson L.J. Myocardial dysfunction associated with brain death: clinical, echocardiographic, and pathologic features. J Heart Lung Transplant 20 (2001) 350-357
19. Zaroff J.G., Babcock W.D., Shiboski S.C., Solinger L.L., and Rosengard B.R. Temporal changes in left ventricular systolic function in heart donors: results of serial echocardiography. J Heart Lung Transplant 22 (2003) 383-388
20. Wood K.E., Becker B.N., McCartney J.G., D'Alessandro A.M., and Coursin D.B. Care of the potential organ donor. N Engl J Med 351 (2004) 2730-2739
21. Reilly P.M., Grossman M., Rosengard B.R., et al. Lung procurement from solid organ donors: role of fluid resuscitation in procurement failures. Chest 110 (1996) 222
22. Totsuka E., Sasaki M., Takahashi K., et al. The effects of intraportal prostaglandin e1 administration on hepatic warm ischemia and reperfusion injury in dogs. Surg Today 25 (1995) 421-428
23. Cittanova M.L., Leblanc I., Legendre C., Mouquet C., Riou B., and Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 348 (1996) 1620-1622
24. Whelchel J., Diethelm A., and Phillips M. The effect of high dose dopamine in cadaveric donor management on delayed graft function and graft survival following renal transplantation. Transplant Proc 18 (1986) 523-527
25. Schneider A., Toledo-Pereyra L.H., Zeichner W.D., Allaben R., and Whitten J. Effect of dopamine and pitressin on kidneys procured and harvested for transplantation. Transplantation 36 (1983) 110-111
26. Marshall R., Ahsan N., Dhillon S., Holman M., and Yang H.C. Adverse effect of donor vasopressor support on immediate and one-year kidney allograft function. Surgery 120 (1996) 663-665 [discussion 666]
27. Wahlers T., Cremer J., Fieguth H.G., et al. Donor heart-related variables and early mortality after heart transplantation. J Heart Lung Transplant 10 (1991) 22-27
28. Yamaoka Y., Taki Y., Gubernatis G., et al. Evaluation of the liver graft before procurement. Significance of arterial ketone body ratio in brain-dead patients. Transpl Int 3 (1990) 78-81
29. Young J.B., Hauptman P.J., Naftel D.C., et al. Determinants of early graft failure following cardiac transplantation, a 10-year, multi-institutional, multivariable analysis. J Heart Lung Transplant 20 (2001) 212
30. Koning O.H., Ploeg R.J., van Bockel J.H., et al. Risk factors for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European multicenter study group. Transplantation 63 (1997) 1620-1628
31. Mackersie R.C., Bronsther O.L., and Shackford S.R. Organ procurement in patients with fatal head injuries. The fate of the potential donor. Ann Surg 213 (1991) 143-150
32. Schnuelle P., Lorenz D., Mueller A., Trede M., and Van Der Woude F.J. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation. Kidney Int 56 (1999) 738-746
33. Gonzalez F.X., Rimola A., Grande L., et al. Predictive factors of early postoperative graft function in human liver transplantation. Hepatology 20 (1994) 565-573
34. Finfer S., Bohn D., Colpitts D., Cox P., Fleming F., and Barker G. Intensive care management of paediatric organ donors and its effect on post-transplant organ function. Intensive Care Med 22 (1996) 1424-1432
35. Schnuelle P., Berger S., de Boer J., Persijn G., and van der Woude F.J. Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation 72 (2001) 455-463
36. Hunt S.A., Baldwin J., Baumgartner W., et al. Cardiovascular management of a potential heart donor: a statement from the transplantation committee of the American College of Cardiology. Crit Care Med 24 (1996) 1599-1601
37. Van den Berghe G., de Zegher F., and Bouillon R. Clinical review 95: acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 83 (1998) 1827-1834
38. Ceballos R. Pituitary changes in head trauma (analysis of 102 consecutive cases of head injury). Ala J Med Sci 3 (1966) 185-198
39. Novitzky D., Cooper D.K., Morrell D., and Isaacs S. Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy. Transplantation 45 (1988) 32-36
40. Bittner H.B., Kendall S.W., Campbell K.A., Montine T.J., and Van Trigt P. A valid experimental brain death organ donor model. J Heart Lung Transplant 14 (1995) 308-317
41. Hing A.J., Hicks M., Garlick S.R., et al. The effects of hormone resuscitation on cardiac function and hemodynamics in a porcine brain-dead organ donor model. Am J Transplant 7 (2007) 809-817
42. Cooper D.K., Novitzky D., and Wicomb W.N. Hormonal therapy in the brain-dead experimental animal. Transplant Proc 20 (1988) 51-54
43. Wicomb W.N., Cooper D.K., and Novitzky D. Impairment of renal slice function following brain death, with reversibility of injury by hormonal therapy. Transplantation 41 (1986) 29-33
44. Rosendale J.D., Kauffman H.M., McBride M.A., et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 75 (2003) 482-487
45. Novitzky D., and Cooper D.K. Results of hormonal therapy in human brain-dead potential organ donors. Transplant Proc 20 (1988) 59-62
46. Goarin J.P., Cohen S., Riou B., et al. The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors. Anesth Analg 83 (1996) 41-47
47. Powner D.J., Hendrich A., Lagler R.G., Ng R.H., and Madden R.L. Hormonal changes in brain dead patients. Crit Care Med 18 (1990) 702-708
48. Howlett T.A., Keogh A.M., Perry L., Touzel R., and Rees L.H. Anterior and posterior pituitary function in brain-stem-dead donors. A possible role for hormonal replacement therapy. Transplantation 47 (1989) 828-834
49. Mariot J., Sadoune L.O., Jacob F., et al. Hormone levels, hemodynamics, and metabolism in brain dead organ donors. Transplant Proc 27 (1995) 793-794
50. Dimopoulou I., Tsagarakis S., Anthi A., et al. High prevalence of decreased cortisol reserve in brain-dead potential organ donors. Crit Care Med 31 (2003) 1113-1117
51. Chen E.P., Bittner H.B., Kendall S.W., and Van Trigt P. Hormonal and hemodynamic changes in a validated animal model of brain death. Crit Care Med 24 (1996) 1352-1359
52. Wheeldon D.R., Potter C.D., Oduro A., Wallwork J., and Large S.R. Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 14 (1995) 734-742
53. Avlonitis V.S., Fisher A.J., Kirby J.A., and Dark J.H. Pulmonary transplantation: the role of brain death in donor lung injury. Transplantation 75 (2003) 1928-1933
54. Novitzky D., Wicomb W.N., Rose A.G., Cooper D.K., and Reichart B. Pathophysiology of pulmonary edema following experimental brain death in the chacma baboon. Ann Thorac Surg 43 (1987) 288-294
55. Fisher A.J., Donnelly S.C., Hirani N., et al. Enhanced pulmonary inflammation in organ donors following fatal non-traumatic brain injury. Lancet 353 (1999) 1412-1413
56. Fisher A.J., Donnelly S.C., Hirani N., et al. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med 163 (2001) 259-265
57. Husain A.N., and Hinkamp T.J. Donor lung pathology: correlation with outcome of transplanted contralateral lung. J Heart Lung Transplant 12 (1993) 932-939
58. Ware L.B., Wang Y., Fang X., et al. Assessment of lungs rejected for transplantation and implications for donor selection. Lancet 360 (2002) 619-620
59. Fisher A.J., Donnelly S.C., Pritchard G., Dark J.H., and Corris P.A. Objective assessment of criteria for selection of donor lungs suitable for transplantation. Thorax 59 (2004) 434-437
60. Gabbay E., Williams T.J., Griffiths A.P., et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med 160 (1999) 265-271
61. Shumway S.J., Hertz M.I., Petty M.G., and Bolman III R.M. Liberalization of donor criteria in lung and heart-lung transplantation. Ann Thorac Surg 57 (1994) 92-95
62. Bhorade S.M., Vigneswaran W., McCabe M.A., and Garrity E.R. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant 19 (2000) 1199-1204
63. Straznicka M., Follette D.M., Eisner M.D., Roberts P.F., Menza R.L., and Babcock W.D. Aggressive management of lung donors classified as unacceptable: excellent recipient survival one year after transplantation. J Thorac Cardiovasc Surg 124 (2002) 250-258